A transformative moment in the global fight against obesity has emerged with the announcement of positive topline results ...

Eli Lilly's pill, orforglipron, is a step closer to becoming the first needle-free alternative in the booming market for weight loss drugs.

Here are five oral obesity candidates that, according to Mizuho’s Graig Suvannavejh, could change the weight loss game.

Healthcare earnings update: 93% of sector firms have reported, highlighting robust revenue growth & few misses.

Detailed price information for Restaurant Brands International (QSR-N) from The Globe and Mail including charting and trades.